Cerebras Systems, widely seen as a formidable challenger to NVIDIA Corporation(NVDA.US) in the AI chip space, is set to list on the Nasdaq on Thursday, May 14 (Ticker: CBRS). Driven by phenomenal market demand, the IPO is over 20 times oversubscribed.

Updated IPO Specs: The final pricing is expected to reach $185 per share—crushing the initial $150–$160 range. The company aims to raise approximately $5.55 billion, bringing its market capitalization to roughly $40 billion. Including restricted stock units (RSUs) and options, its fully diluted valuation stands at around $49 billion, making it the largest IPO of the year so far.

Core Technology: Wafer-Scale AI Inference

While the AI hardware market has heavily focused on "training," Cerebras targets the explosive demand for low-latency AI inference.

• The WSE-3 Chip: Instead of cutting a silicon wafer into individual chips, Cerebras turns an entire wafer into a single massive chip. It bypasses yield issues using a "redundant core" architecture that automatically routes around defects.
• The Memory Advantage: Traditional GPUs suffer from latency when moving data between external memory and compute cores. Cerebras builds memory directly on-chip (44GB SRAM, 21 PB/s bandwidth). This allows its CS-3 systems to run massive models like Meta’s Llama 4 Maverick at more than double the speed of Nvidia's B200 systems.

Why is the Market Buying In?

• Non-Nvidia Alternative: As tech giants scramble to diversify their AI supply chains, Cerebras offers a highly differentiated, vertically integrated solution (hardware, cooling, and cloud services).
• Turning a Profit:  Cerebras flipped a $485 million loss in 2024 into a $237.8 million net profit in 2025, with revenue surging 76% to $510 million.
• Massive Order Backlog ($24.6B):
  • OpenAI:  Signed a >$20B contract through 2028 for low-latency inference clusters. OpenAI also provided a $1B loan and holds a major stake.
  • AWS: Integrating Cerebras CS-3 systems into Amazon Bedrock to create a "decoupled inference solution."
  • CoreWeave: Partnering to deploy 160MW of Cerebras computing power in a massive Canadian AI data center.

Key Risks to Watch

• Customer Concentration: 86% of 2025 revenue came from two UAE-based companies, and over $20B of its backlog is tied solely to OpenAI.
• Supply Chain Bottlenecks: Production is entirely dependent on TSMC's advanced nodes and complex packaging, making it vulnerable to foundry yield fluctuations.
• Nvidia’s Counterattack: Nvidia's upcoming Vera Rubin architecture (expected late 2026) promises a 2.5x leap in inference performance, which could narrow Cerebras’s latency advantage.
• Valuation Surge: Cerebras's valuation has skyrocketed from $23 billion to nearly $49 billion in just a few months, baking in high growth expectations.

What Investment Opportunities and Related Stocks Are Worth Watching?

For investors, besides tracking the company's IPO, keeping an eye on core companies and strategic partners in the related supply chain is also viable:

Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR(TSM.US): As the sole manufacturing foundry, Cerebras uses TSMC's custom N5 process and special reticle stitching technology. Although TSMC might introduce competing SoW-X technology in 2027, in the short term, every giant Cerebras chip manufactured brings substantial revenue opportunities for TSMC.

Global X FTSE Southeast Asia ETF(ASEA.US): Wafer-scale chips are exceptionally difficult to handle in back-end packaging and testing. ASE Technology handles the complex InFO_SoW advanced packaging, playing a crucial role in bringing Cerebras's hardware to practical use.

Amazon.com, Inc.(AMZN.US): By incorporating the CS-3, AWS has strengthened its bargaining power in the AI inference market. This serves as a vital entry point for the company to expand its "non-GPU" ecosystem.

Other Large Enterprises: Giants like QUALCOMM Incorporated(QCOM.US) and Intel Corporation(INTC.US) have laid down defensive strategic bets by investing in Cerebras. If Cerebras enters a strong growth trajectory, these investors stand to gain corresponding returns.

Bottom Line

Cerebras's IPO proves the commercial viability of "non-HBM inference chips." While it won't dethrone Nvidia's GPU dominance in the next five years, it marks the dawn of a "dual-track coexistence" in the AI computing market. The IPO is a massive milestone, but the true commercial test for Cerebras is just beginning.

Read more:

• The Cerebras IPO Is Tomorrow — And Markets Are Flashing A Major Sell Signal
• Cerebras' IPO Frenzy Suggests Wall Street Is Desperate For The Next Nvidia
• Nvidia, AMD, Broadcom And Now Cerebras: AI Chip Trade Gets A New Name
• BRIEF-Arm, Softbank Tried To Buy Cerebras But Were Rejected - Bloomberg News